Thyrotoxicosis occurrence in SARS-CoV-2 infection: A case report

被引:4
|
作者
Pranasakti, Maria Erika [1 ,2 ]
Talirasa, Nimitta [2 ]
Rasena, Henda Ageng [2 ]
Purwanto, Rosita Yunanda [2 ]
Anwar, Sumadi Lukman [3 ]
机构
[1] Dept Internal Med, Rumah Sakit Nas Diponegoro, Semarang, Indonesia
[2] Rumah Sakit Akad UGM, Yogyakarta 55291, Indonesia
[3] Univ Gadjah Mada, Dr Sardjito Hosp, Fac Med,Public Hlth & Nursing, Dept Surg,Div Surg Oncol, Yogyakarta 55281, Indonesia
来源
关键词
Thyrotoxicosis; COVID-19; Crisis; Emergency; Extrapulmonary manifestations; THYROID ASSOCIATION; COVID-19; MANAGEMENT; GUIDELINE; DISEASE;
D O I
10.1016/j.amsu.2022.103700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Coronavirus Disease 2019 (COVID-19) is predominantly manifested as respiratory distress. There are growing reports of extrapulmonary clinical manifestations of COVID-19 in addition to the respiratory symptoms. COVID-19 has been associated with the thyroid function through Angiotensin-converting enzyme 2 (ACE2), the central mechanism through Thyroid Stimulating Hormone (TSH), and direct replication of the virus. Case presentation: A 26-year-old woman presented with complaints of palpitation and abdominal pain for three days. Because the symptoms were worsening, she was brought to the emergency room. Her temperature was 37.9 degrees C without any symptoms of cough, coryza, sneezing, nor headache. Physical examination revealed tremor, tachycardia with 162 beats per minute (bpm), excessive sweating, hyperreflexia of patellar reflex, and no prominent lump in the neck. Electrocardiography (ECG) showed supraventricular tachycardic rhythm (SVT) and 150 J cardioversions were performed. The ECG converted to sinus rhythm, regular, with 120 bpm. Thyroid function tests showed an elevated fT4 level (>7.77 ng/dL) and low TSH level (<0.005 mu IU/mL). Chest X-ray showed slight cardiomegaly without prominent abnormality in the lungs that was confirmed with thoracic computerized tomography. The result of the rapid antigen test for COVID-19 was positive and confirmed with polymerase chain reaction testing. She was then treated in the intensive isolation room with remdesivir, antihyperthyroid, and supportive therapy. As her condition improved, she was shifted to a non-intensive isolation room and was discharged from the hospital at day 7. Discussion: COVID-19 could present as a thyroid crisis as the initial clinical manifestation. Clinicians should be aware that presentation of thyroid dysfunction in a patient without previous endocrine disease could be due to COVID-19 infection. Early recognition, anti-hyperthyroid therapy, and following isolation procedures for COVID19 are required in the emergency condition.
引用
下载
收藏
页数:3
相关论文
共 50 条
  • [1] Perinatal SARS-CoV-2 infection infection: a case report
    Zhuang Siying
    Guo Juanjuan
    Cao Yuming
    Chen Huijun
    Xu Dan
    Li Jiafu
    Zhang Yuanzhen
    中华围产医学杂志, 2020, (02) : 85 - 90
  • [6] Thyrotoxicosis secondary to thyroiditis following SARS-CoV-2 infection
    Coetzee, Ankia
    Bhikoo, Raisa
    Berndorfler, Bianca
    Conradie, Wilhelmina
    Taljaard, Jantjie J.
    Conradie-Smit, Marli
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2021, 26 (02) : 72 - 75
  • [7] Gaucher disease and SARS-CoV-2 infection: A case report
    Urganci, Nafiye
    Dalgic, Nazan
    Guller, Dilek
    Usta, Merve
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 200 - 202
  • [8] Atypical presentation of SARS-CoV-2 infection: A case report
    Li, Rui-Lin
    Chu, Shu-Guang
    Luo, Yu
    Huang, Zhen-Hao
    Hao, Ying
    Fan, Cheng-Hui
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (07) : 1265 - 1270
  • [9] Morphea induced by SARS-CoV-2 infection: A case report
    Pigliacelli, Flavia
    Pacifico, Alessia
    Mariano, Maria
    D'Arino, Andrea
    Cristaudo, Antonio
    Iacovelli, Paolo
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (03) : 377 - 378
  • [10] Pancytopenia Secondary to SARS-CoV-2 Infection—a Case Report
    Neeraj Sharma
    Rajat Shukla
    Rachna Warrier
    Kunal Kumar
    Nalin Singh
    Sourav Ghose
    Vivek Kumar
    SN Comprehensive Clinical Medicine, 4 (1)